New sling aims to stop shoulder pain in stroke survivors
NCT ID NCT04028999
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a custom-made shoulder sling (EO31) in 25 adults who had a stroke within the last 6 months. The goal was to see if the sling could prevent shoulder pain and other complications. Researchers measured success using a goal-setting scale and pain scores. This is a small, early trial, so results are preliminary.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- EO31 shoulder sling (custom-made shoulder support device)
- What this could lead to
- If effective, this sling could help prevent shoulder pain and complications after a stroke, improving recovery and quality of life.
- What could go wrong
- This is a very small, early study with only 25 participants and no comparison group. Results may not apply to all stroke survivors, and the sling may not prevent all shoulder issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
25 people
The number who actually took part.
- Started
-
Jul 2019
- Finished
-
Sep 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Having suffered in the last 6 months maximum a first stroke responsible for hemiplegia. * Finding a clinical 5mm appendix, or with shoulder pain requiring prescription a scarf. * Boston Diagnostic Aphasia Examination (BDAE) \> 3. * Consent of the patient * Patient affiliated or benefiting from a social security scheme Exclusion Criteria: * Stroke recurrence, or stroke more than 6 months-old * Patient already wearing a coaptation scarf * Presence of lymphoedema, venous thrombosis of the upper limb * Neoprene allergy * Severe cognitive impairment: Mini-Mental State (MMS) \<15 * Patient being part of another care protocol * Adult under the protection of justice, tutors or curators * Pregnant or lactating woman.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cerebrovascular accident are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Toulouse
Toulouse, 31000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Botox for stroke recovery: a tiny trial tests whether it can unlock a paralyzed arm
- Decades-Long study of 121,700 nurses aims to uncover hidden heart disease triggers
- Botulinum injection trial for arm spasticity halted early
- Brain training tailored to you: new hope for stroke recovery?
- New powered brace aims to restore mobility for leg weakness patients
- Robot suit helps stroke patients walk again sooner?